Clear All
11888 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
71288-0126-90 71288-0126 Carmustine Carmustine Chemotherapy Alkylating Agent Nitrosourea Intravenous Aug 2, 2021 In Use
00703-4636-01 00703-4636 Streptozocin Zanosar 100.0 mg/mL Chemotherapy Alkylating Agent Nitrosourea Intravenous Dec 3, 2003 In Use
65597-0511-28 65597-0511 QUIZARTINIB VANFLYTA 26.5 mg/1 Chemotherapy Tyrosine Kinase Inhibitor FLT3 Oral Jul 20, 2023 In Use
59651-0582-30 59651-0582 Pazopanib Pazopanib 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, PDGFR, FGFR, Kit, Itk, Lck, c-Fms Oral Dec 4, 2024 In Use
10139-0062-40 10139-0062 Methotrexate Sodium Methotrexate Chemotherapy Antimetabolite Folic Acid Analog Intravenous, subcutaneous, intramuscular May 6, 2013 Jan 31, 2014 No Longer Used
63323-0104-06 63323-0104 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Sep 9, 2022 In Use
71288-0171-11 71288-0171 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 11, 2024 In Use
43598-0048-63 43598-0048 SUNITINIB MALATE SUNITINIB MALATE 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FLT, PDGFR, KIT, RET, CSF Oral Nov 30, 2022 In Use
00004-1101-75 00004-1101 Capecitabine Xeloda 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral Apr 30, 1998 Dec 31, 2014 No Longer Used
63020-0536-30 63020-0536 ponatinib hydrochloride Iclusig 10.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jan 11, 2021 In Use
54868-1126-00 54868-1126 Chlorambucil Leukeran Chemotherapy Alkylating Agent Nitrogen Mustard Oral Feb 13, 1985 Jun 30, 2012 No Longer Used
00955-1746-01 00955-1746 Clofarabine Clofarabine 1.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous May 11, 2017 In Use
63323-0120-20 63323-0120 Cytarabine Cytarabine 100.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intrathecal, Intravenous, Subcutaneous Nov 29, 2004 In Use
31722-0415-31 31722-0415 TEMOZOLOMIDE TEMOZOLOMIDE 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug 23, 2024 In Use
70756-0815-60 70756-0815 Capecitabine Capecitabine 150.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral Sep 1, 2020 In Use
68727-0745-02 68727-0745 (daunorubicin and cytarabine) liposome Vyxeos 100.0 mg/20mL, 44.0 mg/20mL Chemotherapy Antitumor Antibiotic & Antimetabolite Anthracycline & Pyrimidine Analog Intravenous Aug 3, 2017 In Use
52609-3001-00 52609-3001 Melphalan Hydrochloride Alkeran Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jan 1, 2011 In Use
69945-0452-01 69945-0452 sodium iodide i 131 SODIUM IODIDE I 131 1.0 mCi/mL Chemotherapy Radiopharmaceutical Iodine 131 Oral Oct 27, 2015 Jul 1, 2018 No Longer Used
60505-3802-00 60505-3802 Nilotinib Nilotinib 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral May 23, 2025 In Use
68118-0100-01 68118-0100 Streptozocin Zanosar 1.0 g/10mL Chemotherapy Alkylating Agent Nitrosourea Intravenous May 19, 2025 In Use
00069-0201-01 00069-0201 Cladribine Cladribine 1.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Oct 7, 2011 Dec 31, 2017 No Longer Used
62332-0566-90 62332-0566 ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral Jul 9, 2021 In Use
00310-0640-60 00310-0640 SELUMETINIB KOSELUGO 7.5 mg/1 Chemotherapy MEK Inhibitor MEK 1/2 Oral Sep 10, 2025 In Use
47335-0892-72 47335-0892 Temozolomide Temozolomide 100.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb 13, 2014 In Use
42737-0103-05 42737-0103 temozolomide TEMOZOLOMIDE 100.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Dec 31, 2018 Jan 24, 2019 In Use

Found 11888 results — Export these results